M6620 First in Human Study

NCT02157792 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: M6620
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Etoposide
DRUG: Carboplatin
DRUG: Irinotecan

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]